Fact-checked by Grok 2 weeks ago

Pulse pressure

Pulse pressure is the difference between systolic blood pressure and diastolic blood pressure, typically around 40 mm in healthy adults, such as in a reading of 120/80 mm . It arises from the physiological interaction between the heart's —the amount of blood ejected per beat—and the of the arterial system, which refers to the arteries' ability to expand and recoil to accommodate blood flow. This relationship can be approximated by the formula pulse pressure ≈ / arterial , where reduced (stiffer arteries) or increased widens the pressure. Factors like aging, , , , and high cholesterol decrease arterial , thereby elevating pulse pressure, while wave reflections from peripheral arteries can further augment systolic pressure and widen it. Clinically, pulse pressure serves as an important indicator of cardiovascular , with a widened value greater than 60 mm Hg signaling and independently predicting risks for heart disease, , heart attack, and overall mortality—an increase of 10 mm Hg is associated with about a 20% higher cardiovascular risk. Conversely, a narrowed pulse pressure, defined as less than 25% of systolic pressure (e.g., below 25 mm Hg in severe cases), often reflects conditions like , significant blood loss, or , indicating reduced . In specific populations, such as those with or with preserved , elevated pulse pressure correlates with adverse outcomes like hospitalization for and is influenced by factors including and left . Monitoring pulse pressure can guide interventions, such as lifestyle modifications or medications like ACE inhibitors that improve arterial compliance, potentially reducing cardiovascular events.

Fundamentals

Definition

Pulse pressure is defined as the difference between systolic , which represents the peak arterial pressure occurring during cardiac contraction (), and diastolic , the minimum arterial pressure during cardiac relaxation (). This difference quantifies the pulsatile nature of arterial , distinguishing it from the steady-state component of circulation. Physiologically, pulse pressure reflects the interaction between the volume of blood ejected by the left ventricle () and the of the arterial system, which determines how much the arteries can expand and recoil to accommodate the ejected . It embodies the pulsatile component of flow, driven by ventricular ejection and modulated by arterial elasticity, which helps maintain continuous to organs despite intermittent . Reduced arterial , often due to aging or , amplifies this pulsatile stress on the vascular wall. The concept of pulse pressure emerged in the late with the invention of the by Scipione Riva-Rocci in 1896, which first allowed accurate measurement of systolic and diastolic pressures, enabling clinicians like Thomas Lewis to explore arterial waveforms in the early . It is expressed in millimeters of mercury (mmHg), with a typical value around 40 mmHg in healthy adults. Pulse pressure serves as a complementary hemodynamic parameter to (MAP), which averages pressure over the to indicate overall perfusion adequacy.

Calculation and Measurement

Pulse pressure is calculated by subtracting the diastolic blood pressure (DBP) from the systolic (SBP), expressed as: \text{PP} = \text{SBP} - \text{DBP} where values are typically measured in millimeters of mercury (mmHg). To derive pulse pressure, SBP and DBP are first obtained through established techniques. In non-invasive methods, the auscultatory approach uses a with a : the is inflated above the expected SBP to occlude arterial flow, then gradually deflated while listening for —the first sound marks SBP, and the disappearance of sounds indicates DBP. The oscillometric method, common in automated devices, detects oscillations in pressure during deflation; algorithms estimate SBP and DBP from the peak oscillation amplitude and surrounding patterns, respectively. Invasive measurement involves arterial catheterization, where a connected to an intra-arterial directly records the arterial ; SBP is the peak pressure, and DBP is the trough, allowing precise pulse pressure computation from continuous tracings. This method is reserved for critical care settings due to its invasiveness but offers higher fidelity than non-invasive techniques. Accuracy in obtaining SBP and DBP—and thus pulse pressure—depends on factors such as appropriate size and positioning. The bladder width should be at least 40% of the circumference (measured midway between the and ) to avoid overestimation of SBP by up to 20 mmHg with undersized cuffs or underestimation with oversized ones. The 's must be supported at heart level, as unsupported positioning can elevate readings by 10-40 mmHg. For example, in a patient with an SBP of 120 mmHg and DBP of 80 mmHg measured via , the pulse pressure is 40 mmHg. Limitations include errors from irregular heart rhythms, such as , which can cause oscillometric devices to underestimate SBP or overestimate DBP due to variable pulse amplitudes, reducing reliability in up to 20-30% of readings; or invasive methods are preferred in these cases. Improper technique, like rapid cuff deflation (>2-3 mmHg/second), may also lead to inaccurate Korotkoff sound detection.

Physiological Variations

Normal Values

In healthy adults, pulse pressure typically ranges from 30 to 50 mmHg, with a value around 40 mmHg. This value is derived from the difference between systolic and diastolic readings. Slight variations exist by and ; pulse pressure tends to be marginally higher in males compared to females, and higher in non-Hispanic Black individuals than in in U.S. populations. Age-related norms show pulse pressure increasing from approximately 30 mmHg in young adults to 50-60 mmHg in the elderly, primarily due to progressive arterial stiffening that reduces vascular compliance. Large-scale studies, such as the , have documented these average trends, revealing a steady rise in pulse pressure across age groups in community-based cohorts. Daily fluctuations are minor, influenced by the , with pulse pressure generally higher in the morning upon waking and lower during nighttime rest. A pulse pressure below 40 mmHg or above 60 mmHg in healthy individuals warrants further clinical evaluation to assess underlying physiological factors.

Narrow Pulse Pressure

Narrow pulse pressure, typically less than 25 mmHg or below 25% of systolic , physiologically arises from reduced , such as in conditions with low , including or , where the heart ejects less blood per beat.

Wide Pulse Pressure

Wide pulse pressure, often exceeding 60 mmHg, results physiologically from increased stroke volume (e.g., in hyperdynamic states like exercise or anemia) or decreased arterial compliance due to stiffening from aging, atherosclerosis, or other vascular changes, leading to greater pressure transmission from the heart to the periphery.

Clinical Relevance

Cardiovascular Disease Associations

Wide pulse pressure (PP) serves as an independent predictor of adverse cardiovascular outcomes, often providing stronger prognostic value than systolic blood pressure (SBP) alone in certain populations, particularly older adults and those with diabetes. Meta-analyses of cohort studies have shown that elevated PP is associated with heightened risks of myocardial infarction, stroke, and heart failure, with hazard ratios indicating a 15-25% increase in events per 10 mmHg elevation after adjusting for traditional risk factors. For instance, in a pooled analysis of 65,382 patients with atherosclerotic cardiovascular disease from five cardiovascular outcome trials, each 10 mmHg increase in PP was associated with an 11% higher risk of death, myocardial infarction, or stroke (HR 1.11, 95% CI 1.08-1.14). This predictive superiority stems from PP's reflection of arterial stiffness, which captures cumulative vascular aging beyond isolated SBP measurements. The pathophysiological mechanisms linking wide PP to cardiovascular disease involve excessive pulsatile stress on the vascular system, leading to endothelial dysfunction, left ventricular hypertrophy (LVH), and end-organ damage. Increased PP amplifies shear stress and pressure waves transmitted to distal arterioles, impairing endothelial production and promoting and . This contributes to LVH by imposing a chronic volume and pressure overload on the left ventricle, as evidenced in echocardiographic studies where PP >60 mmHg was independently associated with concentric remodeling and diastolic dysfunction. Furthermore, sustained wide PP accelerates end-organ damage, including renal microvascular injury and cerebral small vessel disease, through microvascular and , with longitudinal data showing a dose-dependent relationship to and white matter hyperintensities. In specific conditions like isolated systolic hypertension (ISH), wide PP exceeding 60 mmHg is a hallmark feature and amplifies cardiovascular risk. ISH, characterized by SBP ≥140 mmHg and DBP <90 mmHg, reflects reduced arterial compliance and is linked to a 2-3-fold increase in stroke and heart failure incidence compared to normotension, with PP serving as a key mediator. Similarly, in coronary artery disease (CAD), PP holds prognostic significance; longitudinal studies of post-revascularization patients demonstrate that baseline PP >65 mmHg predicts recurrent ischemia and all-cause mortality (HR 1.32 per 10 mmHg increment), independent of severity or profiles. Evidence from large-scale longitudinal cohorts underscores these associations, including the Risk in Communities (ARIC) study, which reported increased cardiovascular mortality associated with higher pulse pressure. Wide PP also extends to (PAD), where it correlates with accelerated and limb complications.

Role in Sepsis and Shock

In , pulse pressure often widens, typically exceeding 50 mmHg, as a result of profound and a marked reduction in systemic driven by the systemic inflammatory response. This hemodynamic profile characterizes , where high fails to compensate for the drop in diastolic pressure, serving as an early indicator of . Clinicians recognize this widening as a key feature distinguishing from other forms, with low diastolic pressures and warm extremities reflecting the . In contrast, pulse pressure narrows in hypovolemic and cardiogenic shocks due to reduced from volume depletion or impaired cardiac contractility, respectively, leading to a proportional decrease in both systolic and diastolic pressures. Monitoring trends in pulse pressure helps differentiate these states and guide therapy, particularly in assessing fluid responsiveness during . For instance, a narrow pulse pressure in these shock types signals the need for volume expansion, unlike the wide pulse pressure in where vasopressors may be prioritized alongside fluids. Pulse pressure variation (PPV), the cyclic change in pulse pressure during , serves as a dynamic for predicting response to volume resuscitation in critically ill patients with . A PPV threshold greater than 13% indicates likely fluid responsiveness, helping avoid unnecessary fluid administration that could exacerbate in . The Surviving Sepsis Campaign guidelines recommend incorporating PPV, alongside other dynamic measures, for fluid management in settings when invasive monitoring is available.

Effects of Medications and Interventions

Various pharmacological agents influence pulse pressure (PP) through differential effects on systolic blood pressure (SBP) and diastolic blood pressure (DBP). Vasodilators, such as ACE inhibitors and , typically widen PP by preferentially lowering DBP more than SBP, thereby reducing peripheral resistance while maintaining or slightly reducing . For instance, administration in normotensive models markedly increased PP due to a less pronounced reduction in central aortic SBP compared to DBP, with PP elevation linked to altered aortic elasticity and wave reflection dynamics. Similarly, ACE inhibitors like exhibit modest PP widening during chronic use, as they reduce DBP to a greater extent than SBP in hypertensive patients, though less effectively than diuretics. In contrast, beta-blockers narrow PP primarily by decreasing SBP through reductions in and , with minimal impact on DBP. Atenolol, a selective beta-blocker, reduced PP by 4.1 mm after one year of treatment in a randomized trial of hypertensive men, reflecting its negative inotropic and effects that limit . This narrowing is more pronounced in vasodilating beta-blockers like , which combine beta-blockade with nitric oxide-mediated to further attenuate central SBP amplification. Angiotensin receptor blockers (ARBs) effectively reduce wide PP in isolated systolic hypertension (ISH) over time by blocking angiotensin II-mediated , leading to balanced reductions in SBP and DBP. A of 46 randomized controlled trials involving 13,451 participants showed ARBs at maximum doses reduced PP by 3.4 mm compared to , with eprosartan specifically lowering PP from 68 mm to 59 mm in ISH patients after 12 weeks. This effect is attributed to improved arterial and reduced wave reflections, making ARBs a preferred option for elderly patients with ISH. Statins modestly narrow PP through plaque stabilization and improvements in endothelial function, independent of lipid-lowering effects. In a cross-sectional analysis of 16,507 individuals from the CARTaGENE cohort, statin use in primary prevention was associated with a 1.3 mm Hg reduction in central , mediated partly by lower cholesterol levels and enhanced vascular compliance. Recent evidence supports this via mechanisms like reduced and arterial remodeling, though a specific 2024 on plaque stabilization highlights consistent but small PP benefits in high-risk cohorts. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, reduce PP in patients by lowering central SBP and improving vascular stiffness. In a sub-analysis of a randomized trial in patients (many with heart failure comorbidities), empagliflozin decreased central PP by 2.8 mm over 12 weeks, correlated with reductions in ambulatory SBP and inflammatory markers like hsCRP. This effect stems from natriuresis-induced volume reduction and direct vascular benefits, contributing to decreased cardiac . Procedural interventions like surgical (SAVR) normalize PP in by restoring and alleviating outflow obstruction. Preoperatively, severe often presents with narrowed PP due to diminished ; post-SAVR, PP widens toward normal values (typically 40-60 mm Hg) as left ventricular ejection improves, with studies showing acute increases in amplitude and normalization within months. Changes in serve as a surrogate marker for treatment efficacy in trials, reflecting improvements in and cardiovascular risk beyond . In the Veterans Affairs Single-Drug Therapy trial, PP reductions varied by agent class, with greater decreases (e.g., 8.6 mm Hg for hydrochlorothiazide) predicting better long-term vascular outcomes and serving as an endpoint in assessing drug-specific hemodynamic benefits. Similarly, the LIFE study used baseline and on-treatment PP to evaluate prognostic value, confirming its role in monitoring therapeutic responses in ISH cohorts.

References

  1. [1]
    Physiology, Pulse Pressure - StatPearls - NCBI Bookshelf
    Pulse pressure is the difference between systolic and diastolic blood pressures.[1][2][3]Introduction · Cellular Level · Pathophysiology · Clinical Significance
  2. [2]
    Pulse Pressure: What It Means & How To Calculate It
    Pulse pressure is the difference between the upper and lower numbers of your blood pressure. This number can indicate health problems before symptoms.
  3. [3]
    Pulse pressure: An indicator of heart health? - Mayo Clinic
    Aug 18, 2023 · A pulse pressure greater than 40 mm Hg is unhealthy. Checking your pulse pressure may help your care team predict your risk of heart and blood vessel events.
  4. [4]
    Aortic and Arterial Pulse Pressure - CV Physiology
    The rise in aortic pressure from its diastolic to systolic value is determined by the ventricular stroke volume and the compliance of the aorta.
  5. [5]
  6. [6]
    Clinical Significance of Mean and Pulse Pressure in Patients With ...
    Nov 5, 2021 · Pulse pressure defined as the difference between systolic and diastolic blood pressure depends on stroke volume, the elastic properties of the ...Missing: physiology | Show results with:physiology
  7. [7]
    Pulse pressure—a review of mechanisms and clinical relevance
    Pulse pressure arises from the interaction of cardiac ejection (stroke volume) and the properties of the arterial circulation.
  8. [8]
    A Brief Journey into the History of the Arterial Pulse - PMC
    Arterial pulse was studied in China about two and a half thousand years ago. It was first mentioned in the “Internal Medicine Classics, Nei Ching”. This ...
  9. [9]
    Thomas Lewis: Physiologist, Cardiologist, and Clinical Scientist
    Oct 6, 1982 · When he was house physician to Sir Thomas. Barlow he did his first clinical research work on the arterial pulse and blood pressure. He had ...
  10. [10]
    Measurement of Blood Pressure in Humans: A Scientific Statement ...
    Mar 4, 2019 · Oscillometric devices are commonly used to measure BP in clinic, ambulatory, home, and hospital settings, with readings based on the amplitude ...
  11. [11]
    Techniques for Non-Invasive Monitoring of Arterial Blood Pressure
    Jan 8, 2018 · This article describes the different techniques for non-invasive BP measurement, their advantages and limitations, and their clinical applicability.
  12. [12]
    How to measure blood pressure using an arterial catheter
    Apr 24, 2020 · There are several methods to measure BP: intermittent non-invasive measurements using oscillometry, continuous non-invasive measurements ...
  13. [13]
    Blood Pressure Assessment: Overview, Indications, Contraindications
    Sep 5, 2024 · Two methods for measuring a blood pressure exist, the direct and indirect method. The direct method is the criterion standard and consists of ...<|control11|><|separator|>
  14. [14]
    Why Is Cuff Size So Important and Other Factors That Affect Accurate ...
    Jun 6, 2023 · Using a blood pressure (BP) cuff that is too small can result in up to a 20 mm Hg overestimation of systolic BP.
  15. [15]
    Blood pressure monitoring during arrhythmia: agreement between ...
    Since arrhythmia induces irregular pulse waves, it is widely considered to cause flawed oscillometric brachial cuff measurements of blood pressure (BP).
  16. [16]
    Blood Pressure in Patients With Atrial Fibrillation: Part 1 - NIH
    Automated BP measurement in AF is reasonably accurate for systolic BP, but overestimates diastolic BP, although systolic hypertension is more likely to be the ...Missing: size | Show results with:size<|control11|><|separator|>
  17. [17]
    The optimal pulse pressures for healthy adults with different ages ...
    Dec 5, 2022 · Pulse pressure (PP) significantly correlates with health metrics, BMI <25 kg/m 2 and BP <120/80 mmHg.
  18. [18]
    Race/Ethnic and Sex Differentials in Pulse Pressure Among US Adults
    We find higher pulse pressures among racial and ethnic minorities than among non-Hispanic Whites and among males than females.
  19. [19]
    Vascular Stiffness and Increased Pulse Pressure in the Aging ...
    Aging leads to a multitude of changes in the cardiovascular system, including systolic hypertension, increased central vascular stiffness, and increased pulse ...
  20. [20]
    Is Pulse Pressure Useful in Predicting Risk for Coronary Heart ...
    The SBP groups were based on JNC VI criteria : group 1, <120 mm Hg (optimal systolic blood pressure); group 2, 120 to 139 mm Hg (normal and high normal systolic ...
  21. [21]
    Hypertension: Causes and Consequences of Circadian Rhythms in ...
    Mar 14, 2024 · Here, we review the impact of daily rhythms and circadian systems in regulating blood pressure and the onset, progression, and consequences of hypertension.
  22. [22]
    Pulse Pressure: Calculator, Variation, and More - Healthline
    The gap between your systolic and diastolic blood pressure is known as your pulse pressure. This is calculated from the values you get on a blood pressure test.
  23. [23]
    A widened pulse pressure: a potential valuable prognostic indicator ...
    Dec 11, 2015 · Previous studies have showed pulse pressure (PP) to be a predictor of fluid responsiveness in patients with sepsis.
  24. [24]
    Septic Shock: Practice Essentials, Background, Pathophysiology
    Jun 26, 2024 · Patients with this type of shock have high cardiac output, hypotension, a large pulse pressure, a low diastolic pressure, and warm extremities ...Practice Essentials · Background · Pathophysiology · Etiology of Septic Shock
  25. [25]
    Sepsis and Septic Shock - Infections - Merck Manuals
    The pulse is rapid and pounding, and people breathe rapidly. People urinate less often and in smaller amounts, and blood pressure decreases. Later, body ...Causes Of Sepsis And Septic... · Diagnosis Of Sepsis And... · Treatment Of Sepsis And...
  26. [26]
    Can we reliably use pulse pressure as a surrogate for stroke volume ...
    Jun 19, 2025 · This perspective explores the physiological and clinical relevance of pulse pressure (PP) as a potential surrogate for stroke volume (SV), emphasizing its ...<|control11|><|separator|>
  27. [27]
    Shock - StatPearls - NCBI Bookshelf - NIH
    ... pressure less than 90 mm Hg or MAP less than 65 mmHg). ... Distributive shock is the most common type of shock, followed by hypovolemic and cardiogenic shock.
  28. [28]
    Arterial Pulse Pressure Variation with Mechanical Ventilation
    Jan 13, 2018 · Importantly, in this study conducted in patients with septic shock, PPV was a far better predictor of fluid responsiveness than cardiac filling ...Twenty Years Ago: Emergen. · Pulse Pressure Variation · PPV in Specific Clinical .
  29. [29]
    Does pulse pressure variation predict fluid responsiveness in ...
    The median threshold of PPV in predicting fluid responsiveness was 12% (interquartile range 10 to 13%). Table 3. Diagnostic performance of pulse pressure ...
  30. [30]
    Surviving Sepsis Campaign Guidelines 2021 | SCCM
    Oct 3, 2021 · Updated global adult sepsis guidelines, released in October 2021 by the Surviving Sepsis Campaign (SSC), place an increased emphasis on improving the care of ...
  31. [31]
    Vasodilators, Aortic Elasticity, and Ventricular End-Systolic Stress in ...
    Pulse pressure increased markedly after hydralazine. Augmentation index increased after sodium nitroprusside. The effective reflection site distance was ...
  32. [32]
    Pulse Pressure Changes With Six Classes of Antihypertensive ...
    After 1 year, pulse pressure was reduced significantly more (P<0.001) with hydrochlorothiazide (8.6 mm Hg) than with captopril and atenolol (4.1 mm Hg with both); ...
  33. [33]
    Effects of β-Blockers with and Without Vasodilating Properties on ...
    Nov 30, 2015 · β-blocking agents, such as atenolol and metoprolol, negatively affect SBP amplification through a reduction in heart rate and a contemporary ...
  34. [34]
    Blood pressure lowering efficacy of angiotensin receptor blockers for ...
    ARBs reduced trough pulse pressure by about 3 mm Hg. ARBs did not ... Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension ...
  35. [35]
    Antihypertensive Drugs Effect of eprosartan on pulse pressure and ...
    We conclude that eprosartan is an effective and well tolerated antihypertensive drug able to reduce PP in patients with isolated systolic hypertension. This ...
  36. [36]
    Central and Brachial Blood Pressures, Statins, and Low-Density ...
    Jan 2, 2018 · Statins as primary prevention were associated with lower central systolic, diastolic, and pulse pressures (−3.0, −1.6, and −1.3 mm Hg; P<0.001).Missing: narrow | Show results with:narrow
  37. [37]
    How does empagliflozin improve arterial stiffness in patients with ...
    Mar 29, 2019 · Empagliflozin reduced central systolic blood pressure and central pulse pressure, both important surrogate parameters strongly linked to future ...<|separator|>
  38. [38]
    Arterial Pulse Wave Dynamics After Percutaneous Aortic Valve ...
    Sep 12, 2011 · In aortic stenosis, the coronary physiological reserve is impaired. Instead of increasing when heart rate rises, the coronary diastolic suction wave decreases.
  39. [39]
    Recent Clinical Trials of Hypertension Management
    May 20, 2013 · In the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study, pulse pressure was the strongest BP variable predicting future ...